Wuhan Keqian Biology Co.,Ltd reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 775.73 million compared to CNY 604.28 million a year ago. Revenue was CNY 775.73 million compared to CNY 604.28 million a year ago. Net income was CNY 385.91 million compared to CNY 319.74 million a year ago. Basic earnings per share from continuing operations was CNY 0.83 compared to CNY 0.87 a year ago. Diluted earnings per share from continuing operations was CNY 0.83 compared to CNY 0.87 a year ago.